Study title: A 12 month multi-center, randomized, dbdd trial to examine the long-term tolerability of formoterol 1mg via the mddpi, both as b.i.d maintenance therapy and as on-demand-use on top of maintenane, in patients with persistent asthma.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: FORMOTEROL | |||||
ATC code: R03AC13 | |||||
Document link: | |||||
Document date: | |||||
Study number: CFOR2580603 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |